NASA Human Research Program

Profile boundary

NASA's Human Research Program studies and mitigates health and performance risks of human spaceflight using ground research, analogs, the International Space Station, missions, standards, data, and countermeasure development.

Evidence boundary: The official HRP site establishes current research goals and risk areas; it does not validate generation-ship habitability, provide medical advice, establish access to restricted data, or imply NASA endorsement.

Potentially relevant capability areas

• Human-spaceflight risk research, analogs, spaceflight studies, standards support, countermeasure development, health and performance data, and research coordination.

Task-specific matches

A match is bounded to one declared work program. It does not establish a partnership, availability, endorsement, or an organization-wide rank.

• No task-specific match is recorded.

Potential fit—not a relationship

HRP evidence is essential precursor context for radiation, altered gravity, isolation, human factors, medical support, nutrition, sleep, teamwork, and performance. Its present mission horizons and adult astronaut populations do not cover lifelong, reproductive, pediatric, aging, or multigenerational habitation.

Possible bounded engagement, not undertaken: Proposed, not undertaken: use public risk records, standards, solicitations, and datasets; any study or collaboration requires a published eligible route, independent ethics review, human-subject protections, and separate authorization.

Fit and engagement risks

• Current evidence is sparse for partial gravity, combined hazards, lifetime exposure, reproduction, development, aging, and multiple generations.
• Human-subject data may be restricted, small-sample, mission-specific, or privacy-sensitive.
• Medical claims are high consequence and require independent domain review.
• NASA research priorities and risk classifications evolve.

What would change this profile?

Longitudinal and combined-hazard evidence across relevant life stages, an eligible authorized study, open representative data, and independent medical review would change the assessment.